The toxidromes;Les toxidromes

Reanimation

Volumn 15, Issue 5, 2006, Pages 364-369

  Hachelaf, M ^a   Capellier, G ^a   Danel, V ^b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acute poisoning; Antidote; Physical examination; Toxidromes

Indexed keywords

4 METHYLPYRAZOLE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANTIDOTE; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; ATROPINE; BICARBONATE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; BUPRENORPHINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DANTROLENE; DIAMORPHINE; FLUMAZENIL; GLYCOPYRRONIUM BROMIDE; ILLICIT DRUG; LACTATE SODIUM; METHADONE; MUSCLE RELAXANT AGENT; NALOXONE; OPIATE; OPIATE ANTAGONIST; SEDATIVE AGENT; SEROTONIN; TETRAZEPAM; UNINDEXED DRUG; XENOBIOTIC AGENT; ZOPICLONE;

ACIDOSIS; AGITATION; ALCOHOLISM; ANTICHOLINERGIC SYNDROME; ATRIOVENTRICULAR BLOCK; BIOLOGY; BRADYCARDIA; BRADYPNEA; CARDIOVASCULAR EFFECT; CLINICAL FEATURE; COMA; CONFUSION; CONSTIPATION; CONVULSION; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG DEPENDENCE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG INTOXICATION; DYSARTHRIA; DYSPNEA; ELECTROPHYSIOLOGY; EXTRAPYRAMIDAL SYNDROME; HALLUCINATION; HEART PALPITATION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERREFLEXIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOREFLEXIA; HYPOTENSION; INSOMNIA; KIDNEY FAILURE; MALIGNANT HYPERTHERMIA; MEMBRANE STABILIZATION; MIOSIS; MUSCLE HYPOTONIA; MUSCLE RELAXATION; MYDRIASIS; MYOCLONUS; NEUROLOGIC DISEASE; PALLIATIVE THERAPY; PATIENT CARE; PATIENT MONITORING; PHYSICAL EXAMINATION; PHYSICIAN; PRESCRIPTION; PROGNOSIS; PYRAMIDAL SIGN; REPEAT PROCEDURE; RESPIRATION DEPRESSION; SEROTONIN SYNDROME; SHORT SURVEY; SYMPTOMATOLOGY; SYNDROME; TACHYCARDIA; TACHYPNEA; TOXICOLOGY; TREMOR; URINE RETENTION; WITHDRAWAL SYNDROME;

EID: 33749250184     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2006.08.001     Document Type: Short Survey

References (33)

1. Baud F.J., Pegaz-Fiornet B., Lapostolle F., and Bekka F.R. Nouveaux syndromes toxiques aigus d'origine médicamenteuse. Rev. Prat. 47 (1997) 726-730
2. Buckley N.A., Whyte I.M., and Dawson A.H. Diagnostic data in clinical toxicology-Should we use a Bayesian approach?. J. Toxicol. Clin. Toxicol. 40 (2002) 213-222
3. Olson K.R., Pentel P.R., and Kelley M.T. Physical assessment and differential diagnosis of the poisoned patient. Med. Toxicol. 2 (1987) 52-81
4. Buckley N.A., Whyte I.M., Dawson A.H., McManus P.R., and Ferguson N.W. Self-Poisoning in Newcastle, 1987-1992. Med. J. Aust. 167 (1997) 142-146
5. Zimmerman J.L. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit. Care Med. 31 (2003) 2794-2801
6. Baud F.J. Pharmacokinetic-pharmacodynamic relationships. How are they useful in human toxicology?. Toxicol. Lett. 102-103 (1998) 643-648
7. Kulig K. Initial management of ingestions of toxic substances. N. Engl. J. Med. 326 (1992) 1677-1681
8. Sharma A.N., Benitez J.G., Fore C., and Allison L.G. Toxidromes and vital signs, in Toxicology secrets (2001), Hanley and Belfus, Philadephia 10-13
9. Chu J., Wang R.Y., and Hill N.S. Update in Non-pulmonary Critical Care. Am. J. Respir. Crit. Care Med. 166 (2002) 9-15
10. Mrvos R., Krenzelok E.P., and Jacobsen T.D. Toxidromes associated with the most common plant ingestions. Vet. Hum. Toxicol. 43 (2001) 366-369
11. Linden C.H. In: Harood-Nuss A., Linden C.H., Luten R.C., et al. (Eds). General evaluation and management of the poisoned patient. The clinical practice of emergency medicine (1991), Lippincott, Philadelphia 429-437
12. Camidge R., and Bateman D.N. Self-poisoning in the UK: epidemiology and toxidromes. Clin. Med. 3 (2003) 11-114
13. Thanacoody R., and Thomas S. Antidepressant poisoning. Clin. Med. 3 (2003) 114-118
14. Buckley N.A., Whyte I.M., Dawson A.H., and Reith D.A. Preformated admission charts for poisoning admissions facilitate clinical assessment and research. Ann. Emerg. Med. 34 (1999) 476-482
15. Bailey B., Buckley N.A., and Amre D.K. A meta-analysis of prognostic indicators to predict seizures,arrhythmias or death after tricyclic antidepressant overdose. J. Toxicol. Clin. Toxicol. 42 (2004) 877-888
16. Caravati E.M., and Bossart P.J. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. Clin. Toxicol. 29 (1991) 31-43
17. Hulfén B.A., Adams R., Askenasi R., Dallos V., Dawling S., Volans G., et al. Predicting severity of tricyclic antidepressant overdose. Clin. Toxicol. 30 (1992) 161-170
18. Langemeijer J.J.M., De Wildt D.J., De Groot G., and Sangster B. Intoxication with beta-sympathicolytics. Neth. J. Med. 40 (1992) 308-315
19. Mofenson H.C., and Greensher J. The unknown poison. Pediatrics 54 (1974) 336-342
20. Priori S.G., Napolitano C., Schwartz P.J., Grillo M., Bloise R., Ronchetti E., et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
21. Flomenbaum N., Goldfrank L.R., and Roberts J.R. In: Schwartz G.R., Cayten C.G., Mangelsen M.A., et al. (Eds). Toxicologic evaluation and management by clinical presentation. Principles and practice of emergency medecine (1992), W.B. Saunders, Philadelphia 2951-2963
22. Lejoyeux M., Rouillon F., Léon E., and Adès J. Le syndrome sérotoninergique : revue de la littérature et description d'une étude originale. Encephale 21 (1995) 537-543
23. Gillman P.K. The serotonin syndrome and its treatment. J. Psychopharmacol. 13 (1999) 100-109
24. Jaunay E., Gaillac V., and Guelfi J.D. Le syndrome sérotoninergique : Quel traitement et quand?. Presse Med. 30 (2001) 1695-1700
25. Mueller P.D., and Korey W.S. Death by «Ecstasy»: The serotonin syndrome?. Ann. Emerg. Med. 32 (1998) 377-380
26. Sternbach H. The serotonin syndrome. Am. J. Psychiatry 148 (1991) 705-713
27. Abu-Kishk I., Toledano M., Reis A., Daniel D., and Berkovitch M. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic. J. Toxicol. Clin. Toxicol. 42 (2004) 921-925
28. Levenson J.L. Neuroleptic malignant syndrome. Am. J. Psychiatry 142 (1985) 1137-1145
29. Durocher A., Chopin C., Gosselin B., and Wattel F. Rhabdomyolyses toxiques et médicamenteuses. Rev. Med. Interne 1 (1980) 223-226
30. Beyeler C., Fish H.U., and Preisig R. The disulfiram alcohol reaction : factors determining and potential tests predicting severity. Alcohol. Clin. Exp. Res. 9 (1985) 118-124
31. Deslandes P.N., Pache D., and Sewell R.D. Drug dependance: neuropharmacology and management. J. Pharm. Pharmacol. 54 (2002) 885-895
32. Ellenhorn M.J., and Barcelous D.G. Ellenhorn's medical toxicology. Medical Toxicology: diagnosis and treatment of human poisonning (1997), Williams and Wilkins, Baltimore 1140-1146
33. Ronnback L., Eriksson P.S., Zeuchner J., Rosengren L., and Wronski A. Aspects of abstinence after morphine ingestion. Pharmacol. Biochem. Behav. 28 (1987) 87-93